Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults
- DOI
- 10.1016/j.vaccine.2018.08.051
- Published
- 2018-10
- Container
- Vaccine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2018.08.051,
title = {Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults},
author = {Donald Brandon and Murray Kimmel and Sherine O. Kuriyakose and Lusiné Kostanyan and Narcisa Mesaros},
year = {2018},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2018.08.051},
url = {https://doi.org/10.1016/j.vaccine.2018.08.051}
}RIS
TY - JOUR TI - Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults AU - Donald Brandon AU - Murray Kimmel AU - Sherine O. Kuriyakose AU - Lusiné Kostanyan AU - Narcisa Mesaros PY - 2018 JO - Vaccine DO - 10.1016/j.vaccine.2018.08.051 UR - https://doi.org/10.1016/j.vaccine.2018.08.051 ER -
APA
Brandon, D., Kimmel, M., Kuriyakose, S. O., Kostanyan, L., & Mesaros, N. (2018). Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults. Vaccine. https://doi.org/10.1016/j.vaccine.2018.08.051
Source records
- crossref · retrieved 2026-09-27T05:40:22.341Z